Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Cannabis ETF"


19 mentions found


Cannabis stocks soared on Tuesday after the AP reported that the DEA will soon reclassify marijuana. The move would ease restrictions on cannabis and acknowledge that it has medicinal benefits. According to the report, the DEA decision would be sent to the White House Office of Management and Budget for review. AdvertisementCannabis stocks soared on Tuesday after the AP reported that the US Drug Enforcement Administration is on the verge of reclassifying marijuana. Shares of Canopy Growth soared 37%, Village Farms stock soared 20%, and the AdvisorShares Pure Cannabis ETF jumped 18%.
Persons: Organizations: AP, White, Office of Management, Service, US Drug, Village, Cannabis
Trade Roots, a Wareham-based Cannabis dispensary grows cannabis plants for making CBD with THC in their greenhouse, and manufactures CBD products for sale in their shop and distribution to buyers. Cannabis stocks leapt on Tuesday afternoon, buoyed by a Biden administration decision to ease federal restrictions on marijuana. The U.S. Drug Enforcement Administration is expected to approve an opinion by the Department of Health and Human Services to reclassify marijuana as a Schedule III substance, NBC News reported, citing four sources with knowledge of the decision. Marijuana has been labeled a Schedule I substance for more than 50 years, the same as methamphetamine and heroin. Investors in cannabis stocks cheered the move, with the AdvisorShares Pure US Cannabis ETF (MSOS ) surging nearly 20% in afternoon trading.
Organizations: U.S . Drug, Department of Health, Human Services, NBC News, Marijuana, Drugs, Cannabis ETF Locations: Wareham, U.S
An ETF that's down 80% from its all-time high or one that is up 110% from its all-time low? Both of these outlandish percent moves describe the AdvisorShares Pure US Cannabis ETF (MSOS) , which is down 80% from its February '21 high and now up 110% from its October '23 low. The only discernable point here is the spike in early February'21, which lined up exactly with the ETF's all-time high. The ETF had flirted with piercing this line before – most recently this past fall - but each attempt failed before 2024. Any index, ETF or stock that's in a long-term uptrend is trading above an upward sloping 200-day moving average.
Persons: Hope, we're, MSOS, Frank Cappelleri Organizations: Cannabis ETF
Cannabis stocks aren't the only ones that were riding high in early 2021. Those changes have yet to come on a federal level, and dimming enthusiasm from investors, among other factors, has led to a major slide in pot stocks. The AdvisorShares Pure US Cannabis ETF, which holds U.S.-based cannabis companies, currently trades for $6.80 a share, down from nearly $52 in February 2021. But for experts in the space, the question surrounding cannabis legalization (and a subsequent boom in the industry) isn't if, but when. "Legalization of cannabis is inevitable," says Jaret Seiberg, a policy analyst at TD Cowen.
Persons: Jaret Seiberg, Cowen, Brady Cobb, Mike Johnson's ascendency, Johnson, Cobb, Joe Biden, Jason Wild Organizations: Democratic, Cannabis ETF, Department of Health, Human Services, Bloomberg, HHS, Drug Enforcement Agency, JW Asset Management Locations: Ohio, Massachusetts
REUTERS/Erica Dischino/ File Photo Acquire Licensing RightsSept 27 (Reuters) - A U.S. Senate committee on Wednesday voted to advance a marijuana banking bill, raising hopes for the cash-dependent cannabis sector to get access to regular banking services. The Secure and Fair Enforcement Regulation Banking Act (SAFER) bill, introduced by a bipartisan group of senators last week, will now move to the Senate floor. Shares of SNDL (SNDL.O), Trulieve Cannabis (TRUL.CD), Cronos Group (CRON.TO), rose between 1% and 3% following the vote. An earlier version of the bill, the SAFE Banking Act, had failed to secure a Senate vote despite the House of Representatives passing it seven times. "Realizing this first vote out of the Senate signals strong bipartisan support from both chambers of Congress," said Trulieve CEO Kim Rivers.
Persons: Erica Dischino, Kim Rivers, Arunima Kumar, Sourasis Bose, Sriraj Organizations: Red, REUTERS, U.S, Cronos, Cannabis ETF, Holdings, SAFE, U.S . Department of Health, Human Services, Drug Enforcement Agency, Thomson Locations: Red Lake, Red Lake , Minnesota, U.S, Bengaluru
In volatile trading, the U.S.-listed shares of several cannabis firms rose immediately after the Senate vote. Investors expected it to exit the banking committee. An earlier version of the bill, the SAFE Banking Act, had failed to secure a Senate vote despite being passed seven times by the U.S House of Representatives. As a result, legal cannabis companies are denied access to financial services. To get it through the Senate banking committee is a major achievement," Boris Jordan, billionaire founder of Curaleaf Holdings, said in an interview.
Persons: Chris Wattie, Jesse Redmond, Redmond, We've, it's, Boris Jordan, Jordan, Chibuike Oguh, Suzanne McGee, Michelle Price, Lance Tupper, Bill Berkrot Organizations: Canopy Growth Corporation, REUTERS, U.S, U.S . Senate, Aurora, Cronos, SNDL Inc, Curaleaf Holdings, Tilray, Cannabis ETF, Cannabis, Tower Research, Investors, SAFE, Thomson Locations: Smiths Falls , Ontario, Canada, U.S, New York, Bengaluru
The Securities and Exchange Commission chair and the rest of the commissioners will vote on a new rule that would clarify what investment funds can call their funds. The SEC wants to clarify rules that govern what investment funds can name their funds. This is especially evident in the naming of funds, whether they are mutual funds or exchange-traded funds. The SEC proposal "would modernize the Names Rule for today's markets," he added. If the proposed rule is adopted, some funds may be under pressure to change their names.
Persons: Gary Gensler, Gensler, there's, There's, Dorothy M, Donohue Organizations: The Securities, Exchange Commission, SEC, Electric Vehicle Mutual Fund, Electric Vehicle, Nvidia, Microsoft, Electric Vehicles, The Investment Company Institute
An employee of Aurora Deutschland GmbH, a manufacturer of medical Cannabis products, inspects a flowering Cannabis plant in a greenhouse in Leuna, Germany September 11, 2023. Marijuana-related ETFs are soaring in September as investors flood back into the sector after months of waning interest. It marked a swift turnaround for a quasi-legal industry curtailed by the anemic pace of federal reform. Last month's announcement also sent shares of several cannabis companies higher, including Canopy Growth, Tilray Brands and Cronos Group. At the time of the closure announcement, fund co-founder Morgan Paxhia told CNBC that it was not "immune to the broader macroeconomic environment and, more specifically, the dramatic shift in investor sentiment that has impacted the cannabis industry."
Persons: Canaccord, Matt Bottomley, Morgan Paxhia Organizations: Aurora Deutschland GmbH, U.S . Department of Health, Human Services, Dow Jones Industrial, Dow, Tilray Brands, Cronos Group, Marijuana, CNBC Locations: Leuna, Germany
"We've seen most cannabis ETFs rally over 30% since the news broke last week on this recommendation," Amplify ETFs CEO Christian Magoon told CNBC's Courtney Reagan on "ETF Edge" on Wednesday. The Roundhill Cannabis ETF (WEED) has soared nearly 71% since the announcement, while the AdvisorShares Pure US Cannabis ETF (MSOS ) and AdvisorShares Pure Cannabis ETF (YOLO) have jumped 64% and 45%, respectively. "Consumer packaged goods and pharmaceutical companies are going to be able to now look at these cannabis companies as M&A targets to partner with them." "The great thing about the ETF industry is there's a lot of opportunity," Lydon said in the same interview on Wednesday. Lydon pointed out that Amplify ETFs holds a great "first mover advantage" with its pair of cannabis-based funds.
Persons: Christian Magoon, CNBC's Courtney Reagan, Magoon, marijuana's, Tom Lydon, Lydon Organizations: Cannabis ETF, U.S . Department of Health, Human Services, HHS, DEA, Cannabis, VettaFi Locations: YOLO
Cannabis ETFs are catching fire in September
  + stars: | 2023-09-08 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com   time to read: +1 min
The volatile cannabis sector is on the upswing in September, boosting a group of exchange-traded funds that have largely struggled over the past two years as legalization of marijuana in the U.S. remains in limbo. The AdvisorShares Pure US Cannabis ETF (MSOS) has jumped 18% in the first four trading days of the month, building on a rally that began in late August. Smaller funds such as the Roundhill Cannabis ETF (WEED) and the ETFMG U.S. MSOS 1M mountain Weed stocks are surging in September, as shown by the MSOS ETF. The struggles for marijuana ETFs have extended beyond price movements, as cannabis remains illegal at the federal level.
Organizations: Cannabis ETF, Cannabis, Thumb Industries, Politico Locations: U.S, Washington
Shares of cannabis firms Cronos Group (CRON.TO), OrganiGram Holdings (OGI.TO), Aurora Cannabis (ACB.TO), Canopy Growth (WEED.TO) jumped between 6% and 25%. Verano Holdings (VRNO.CD), Green Thumb Industries (GTII.CD), Cresco Labs (CL.CD) and Curaleaf Holdings (CURA.CD) and Goodness Growth (GDNS.CD) rose between 15% and 37%. "Certainly moving cannabis off of Schedule 1 is the right decision and long overdue. The firm held investments in cannabis retailer and producer Green Thumb, and cannabis data platform Flowhub, according to its website. Reporting by Arunima Kumar in Bengaluru; Editing by Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.
Persons: cagey, Ty Collin, Patrick Rea, Green, Arunima Kumar, Sriraj Organizations: Cronos Group, OrganiGram Holdings, Verano Holdings, Green Thumb Industries, Cresco Labs, Curaleaf Holdings, Cannabis ETF, U.S . Department of Health, Human Services, Drug Enforcement Agency, Banking, Poseidon Garden Ventures, Thomson Locations: U.S, Aurora, Bengaluru
The Drug Enforcement Agency received an official recommendation to downgrade marijuana. Currently, pot is classified as a Schedule I drug, on par with heroin. Marijuana's category downgrade would be a serious shift for the cannabis industry, easing restrictions on its use. The largest marijuana exchange traded fund, the AdvisorShares Pure US Cannabis ETF, gained around 19%. It was outpaced by the Roundhill Cannabis ETF, at 20%.
Persons: Anne Milgram, Cronos, SNDL Organizations: Drug Enforcement Agency, Service, Bloomberg, Department of Health, Human Services, Drug, DEA, Cannabis ETF, Cannabis, Aurora Cannabis Locations: Wall, Silicon
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOptions Action: Options trader bets cannabis ETF hits $10 by JanuaryMike Khouw, Optimize Advisors president, joins CNBC’s Melissa Lee and the Options Action traders to talk a bullish bet in the cannabis space.
Persons: Mike Khouw, Melissa Lee Organizations: Options
A leading exchange-traded fund in the cannabis space will close up shop as investor interest in the legally restricted industry wanes. AdvisorShares, the largest cannabis fund manager, said its Poseidon Dynamic Cannabis ETF will see its final day of trading Aug. 25. The closure comes as investors lose interest in the quasi-legal cannabis industry that has struggled to scale. Meanwhile, Pure US Cannabis ETF , another fund in the industry by AdvisorShares, plummeted about 60% during the same period. Mastercard, in a move that further alienates the cannabis industry from big banking, announced last month it will stop allowing cannabis transactions on its debit cards to be in compliance with federal law.
Persons: Emily, Morgan Paxhia Organizations: Florida Supreme, New York Stock Exchange, CNBC, Poseidon Investment Management, US Cannabis ETF, AdvisorShares, Cresco Labs, Columbia Care, Mastercard Locations: Florida, U.S
Cannabis stocks jumped Thursday as lawmakers sought again to pass a bill to protect banks that work with legal pot firms. The SAFE Banking Act of 2023 was refiled by Democrats and Republicans in the House and Senate. The Secure and Fair Enforcement, or SAFE, Banking Act was refiled late Wednesday by House and Senate lawmakers from both the Democratic and Republican parties. They say the proposal is aimed at dealing with safety concerns stemming from legal cannabis businesses being locked out of banking services. Merkley said there's now a path for the first time for the SAFE Banking Act to move through the Senate Banking Committee and to a Senate floor vote.
New York CNN —Oil stocks skyrocketed in 2022, so it’s no surprise funds that track the energy sector were Wall Street winners this year. The iShares MSCI Turkey exchange-traded fund had more than doubled as of December 19, according to data from Morningstar Direct. The Turkish economy has slowed recently as unemployment has risen, but the instability has not hurt Turkish stocks. Other US and international oil funds and ETFs were also at the top of Morningstar Direct’s list. (Morningstar Direct provided CNN Business with a ranking of the best and worst mutual funds and ETFs for 2022, excluding so-called leveraged funds that make outsized bets on stock market indexes.)
Even if the election results match expectations, stocks may still rally as some unknowns are removed. Broad sector ETFs from firms like iShares, State Street and Vanguard are one way to play these sectors, offering cheap broad exposure. For example, the Industrial Select Sector SPDR ETF (XLI) and Vanguard Communications Services ETF (VOX) both have an expense ratio of 0.10%. Under-the-radar elections Federal elections are not the only contests on Tuesday that could move stocks. The biggest marijuana ETFs — AdvisorShares Pure US Cannabis ETF (MSOS) and ETFMG Alternative Harvest ETF (MJ) — are each down more than 50% for the year.
Regardless of the winner, past midterm elections have ushered in a period of positive market performance, something investors would welcome after a year in which the S&P 500 has declined by nearly 21%. The S&P 500 aerospace and defense index (.SPLRCAED) is up nearly 10% this year. HEALTHCAREPharmaceutical and biotech stocks may benefit in a Republican victory, after Democrats recently pushed through a law aimed at lowering prescription drug prices. The S&P 500 healthcare sector (.SPXHC) is down some 7% in 2022, while the S&P 500 pharmaceuticals index (.SPLRCCARG) is up about 1%. Therefore Republican victory in the House or Senate "probably means a legislative standstill, implying an incremental positive for the category," the said.
Leon Cooperman ripped into Green Thumb Industries executives and accused them of insider selling. Green Thumb Industries' stock is down by 47% since January 1. During Green Thumb Industries' investor call on Wednesday evening, the hedge-fund billionaire Leon Cooperman ripped into the Chicago cannabis giant's CEO, Ben Kovler, over what Cooperman said was rampant insider selling by the company's executives. "I currently remain the largest shareholder in Green Thumb, and management continues to believe in the $75 billion to $100 billion opportunity ahead for both Green Thumb and the industry at large." Despite mixed results in the quarter, analysts are optimistic about Green Thumb Industries' long-term growth prospects.
Total: 19